Presentation is loading. Please wait.

Presentation is loading. Please wait.

Encouraging Results of a Phase II Trial of Inhaled Fluticasone Propionate, Azithromycin, and Montelukast (FAM) May Maintain Lung Function in Bronchiolitis.

Similar presentations


Presentation on theme: "Encouraging Results of a Phase II Trial of Inhaled Fluticasone Propionate, Azithromycin, and Montelukast (FAM) May Maintain Lung Function in Bronchiolitis."— Presentation transcript:

1 Encouraging Results of a Phase II Trial of Inhaled Fluticasone Propionate, Azithromycin, and Montelukast (FAM) May Maintain Lung Function in Bronchiolitis Obliterans Syndrome (BOS) after Hematopoietic Cell Transplantation  Kirsten M. Williams, MD, Guang-Shing Cheng, MD, Iskra Pusic, MD, Madan H. Jagasia, MD, MBBS, MS, Linda J. Burns, MD, Vincent T. Ho, MD, Joseph Pidala, MD, PhD, Jeanne Palmer, MD, Laura Johnston, MD, Sebastian Mayer, MD, David A. Jacobsohn, MD, Paul J. Martin, MD, Barry E. Storer, PhD, Yoshihiro Inamoto, MD PhD, Xiaoyu Chai, MS, Mary E.D. Flowers, MD, Stephanie J. Lee, MD, MPH  Biology of Blood and Marrow Transplantation  Volume 21, Issue 2, Pages S61-S62 (February 2015) DOI: /j.bbmt Copyright © Terms and Conditions

2 Figure Change in individual and mean percentage FEV1% over time.
Biology of Blood and Marrow Transplantation  , S61-S62DOI: ( /j.bbmt ) Copyright © Terms and Conditions


Download ppt "Encouraging Results of a Phase II Trial of Inhaled Fluticasone Propionate, Azithromycin, and Montelukast (FAM) May Maintain Lung Function in Bronchiolitis."

Similar presentations


Ads by Google